Search Results for: EnliveX

Innovations in Life Sciences

On 2nd Mar, the JNF is hosting a webinar featuring Israeli and US innovations in the Life Sciences. It includes the Chief Scientific & Medical Officer Prof. Dror Mevorach of Israel’s Enlivex Therapeutics – developer of COVID-19 “cure” Allocetra.  Registration … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Good Phase 2 results of Covid-19 treatment

Allocetra from Israel’s Enlivex Therapeutics (reported here previously) has cured the majority of the 37 seriously and critically ill Covid-19 patients in its Phase 1b and 2 trials. 33 patients were discharged from hospital an average of under 6 days … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Five patients saved by new Covid-19 treatment

Israel’s Enlivex Therapeutics reported positive results in its clinical Covid-19 trial of its Allocetra treatment (reported here previously) Five seriously ill patients made complete recoveries, an average 8.5 days after receiving the treatment.at Jerusalem’s Hadassah hospital. https://www.jpost.com/israel-news/5-patients-leave-hadassah-coronavirus-free-after-clinical-trial-644071 https://www.calcalistech.com/ctech/articles/0,7340,L-3852110,00.html

Posted in Israel's Medical Achievements | Leave a comment

Treatment for severe victims of coronavirus

As reported previously, (see here) the Allocetra treatment from Israel’s Enlivex cures patients suffering severe sepsis. Allocetra is now being offered to governments for the thousands of coronavirus patients suffering sepsis-induced organ failure due to overactive immune responses. https://www.jpost.com/HEALTH-SCIENCE/Israeli-company-ready-to-assist-coronavirus-victims-with-novel-drug-617777

Posted in Israel's Medical Achievements | Leave a comment

Good results in sepsis treatment trial

As reported previously (see here) Israel’s Enlivex Therapeutics has developed Allocetra which rebalances the immune system. Allocetra was given to six patients suffering from severe sepsis at Hadassah hospital in Jerusalem. All survived. http://www.xinhuanet.com/english/2019-11/04/c_138528152.htm

Posted in Israel's Medical Achievements | Leave a comment

Israeli bio-techs merge

I reported previously (see here) on Jerusalem-based immunotherapy company Enlivex Therapeutics. Enlivex has merged with Tel Aviv-headquartered Bioblast (see here), which is developing treatments for rare genetic diseases. https://www.calcalistech.com/ctech/articles/0,7340,L-3759270,00.html

Posted in Israel's Medical Achievements | Leave a comment

Funds for immunotherapy treatment

I reported previously (three times) on Israel’s Enlivex and its Allocetra / Apocell treatment to prevent Graft vs Host Disease – a common problem after bone marrow transplants.  Elivex has just received $8 million of funding which will help it … Continue reading

Posted in Economy & Business | Leave a comment

Bone marrow treatment gets boost

In January I mentioned Apocell from Israeli biotech Enlivex, which prevents GVHD rejection of bone marrow transplants. Now, the treatment has received US FDA “orphan” status due to its importance and lack of alternatives for treating the unwanted autoimmune response. … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Israeli treatment helps bone marrow transplants

Israeli biotech Enlivex has developed a treatment called ApoCell that triggers a response from the immune system to reduce adverse reactions during bone marrow transplants. It prevents Graft vs Host Disease (GVHD), which affects around 70% of transplant patients. http://unitedwithisrael.org/enlivex-innovation-leads-to-effective-new-cancer-treatment/ … Continue reading

Posted in Israel's Medical Achievements | Leave a comment